Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshie Morimoto

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Optics Express|May 5, 2019
Design for polymer optical waveguides realizing efficient light coupling via 45-degree mirrorsYoshie Morimoto, Takaaki Ishigure
Optics Express|February 25, 2016
Low-loss light coupling with graded-index core polymer optical waveguides via 45-degree mirrorsYoshie Morimoto, Takaaki Ishigure
Cureus|April 3, 2023
Durable Response to Chemoimmunotherapy of a Lung Adenocarcinoma Harboring a MET Exon 14 Skipping MutationNaohiro Nitta, Yoshie Morimoto, Nozomi Tani, et al.
Cureus|February 22, 2024
Safety of First-Line Nivolumab Plus Ipilimumab in Very Old (≥ 80 Years) Patients With Unresectable Malignant Pleural Mesothelioma: A Retrospective Single-Center Case SeriesTakayuki Shimamoto, Yoshie Morimoto, Naohiro Nitta, et al.
Biochemical and Biophysical Research Communications|November 18, 2018
Interferon-β signal may up-regulate PD-L1 expression through IRF9-dependent and independent pathways in lung cancer cellsYoshie Morimoto, Tsunao Kishida, Shin-Ichiro Kotani, et al.
Cancer Treatment Reviews|October 10, 2020
Association of immune checkpoint inhibitors with respiratory infections: A reviewRyosuke Hamashima, Junji Uchino, Yoshie Morimoto, et al.
Translational Lung Cancer Research|October 17, 2022
Changes in serum transforming growth factor-beta concentration as a predictive factor for radiation-induced lung injury onset in radiotherapy-treated patients with locally advanced lung cancerYurie Seto, Yoshiko Kaneko, Takako Mouri, et al.
Journal of Clinical Medicine|May 10, 2020
Immune Checkpoint Inhibitors for Lung Cancer Treatment: A ReviewKeisuke Onoi, Yusuke Chihara, Junji Uchino, et al.
Internal Medicine (Tokyo, Japan)|June 7, 2021
Late-onset Pleural and Pericardial Effusion as Immune-related Adverse Events after 94 Cycles of NivolumabRyo Sawada, Yohei Matsui, Junji Uchino, et al.
Journal of Clinical Medicine|July 3, 2020
Endocrinopathies Associated with Immune Checkpoint Inhibitor Cancer Treatment: A ReviewNaoko Okura, Mai Asano, Junji Uchino, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Optics Express|May 5, 2019
Design for polymer optical waveguides realizing efficient light coupling via 45-degree mirrorsYoshie Morimoto, Takaaki Ishigure
Optics Express|February 25, 2016
Low-loss light coupling with graded-index core polymer optical waveguides via 45-degree mirrorsYoshie Morimoto, Takaaki Ishigure
Cureus|April 3, 2023
Durable Response to Chemoimmunotherapy of a Lung Adenocarcinoma Harboring a MET Exon 14 Skipping MutationNaohiro Nitta, Yoshie Morimoto, Nozomi Tani, et al.
Cureus|February 22, 2024
Safety of First-Line Nivolumab Plus Ipilimumab in Very Old (≥ 80 Years) Patients With Unresectable Malignant Pleural Mesothelioma: A Retrospective Single-Center Case SeriesTakayuki Shimamoto, Yoshie Morimoto, Naohiro Nitta, et al.
Biochemical and Biophysical Research Communications|November 18, 2018
Interferon-β signal may up-regulate PD-L1 expression through IRF9-dependent and independent pathways in lung cancer cellsYoshie Morimoto, Tsunao Kishida, Shin-Ichiro Kotani, et al.
Cancer Treatment Reviews|October 10, 2020
Association of immune checkpoint inhibitors with respiratory infections: A reviewRyosuke Hamashima, Junji Uchino, Yoshie Morimoto, et al.
Translational Lung Cancer Research|October 17, 2022
Changes in serum transforming growth factor-beta concentration as a predictive factor for radiation-induced lung injury onset in radiotherapy-treated patients with locally advanced lung cancerYurie Seto, Yoshiko Kaneko, Takako Mouri, et al.
Journal of Clinical Medicine|May 10, 2020
Immune Checkpoint Inhibitors for Lung Cancer Treatment: A ReviewKeisuke Onoi, Yusuke Chihara, Junji Uchino, et al.
Internal Medicine (Tokyo, Japan)|June 7, 2021
Late-onset Pleural and Pericardial Effusion as Immune-related Adverse Events after 94 Cycles of NivolumabRyo Sawada, Yohei Matsui, Junji Uchino, et al.
Journal of Clinical Medicine|July 3, 2020
Endocrinopathies Associated with Immune Checkpoint Inhibitor Cancer Treatment: A ReviewNaoko Okura, Mai Asano, Junji Uchino, et al.
Pageof 4